HPV-associated p16-expression and response to radiobiological modifications of radiotherapy in head and neck cancer: results from the randomised DAHANCA trials

被引：5

作者：

Lassen, P. ^{[7
]}

Eriksen, J. G. ^{[7
]}

Krogdahl, A. ^{[6
]}

Specht, L. ^{[5
]}

Overgaard, M. ^{[4
]}

Andersen, E. ^{[3
]}

Johansen, J. ^{[2
]}

Andersen, L. J. ^{[1
]}

Overgaard, J. ^{[7
]}

机构：

[1] Aalborg Hosp, Dept Oncol, Aalborg, Denmark

[2] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark

[3] Herlev Hosp, Dept Oncol, Copenhagen, Denmark

[4] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark

[5] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark

[6] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark

[7] Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark

来源：

EJC SUPPLEMENTS | 2009年 / 7卷 / 03期

关键词：

D O I：

10.1016/S1359-6349(09)72054-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：11 / 11

页数：1

共 50 条

[21] Is p16 Better and More Cost Effective Than HPV ISH for Detection of HPV-Associated Head and Neck Squamous Cell Carcinoma?
Primeaux, T. M.
Thomas, J.
LABORATORY INVESTIGATION, 2011, 91 : 282A - 282A
[22] Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial
Overgaard, J
Eriksen, JG
Nordsmark, M
Alsner, J
Horsman, MR
LANCET ONCOLOGY, 2005, 6 (10): : 757 - 764
[23] Correlation of HPV-16, HPV-18 Genotypes with p16 Expression in Head and Neck Cancer: A Study from Western India
Jethva, Disha D.
Kapadia, Trushika R.
Gajjar, Kinjal K.
Mandalia, Toral H.
Vora, Hemangini H.
Trivedi, Priti
Patel, Jayendrakumar B.
SOUTH ASIAN JOURNAL OF CANCER, 2024,
[24] Validation of two biologically distinct HPV-associated head and neck cancer subtypes and correlation with E5 expression
Zuo, Zhixiang
Khattri, Arun
Keck, Michaela K.
Cohen, Ezra E. W.
Lingen, Mark W.
Vokes, Everett E.
Seiwert, Tanguy Y.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[25] Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab
Heiduschka, Gregor
Grah, Anja
Oberndorfer, Felicitas
Seemann, Rudolf
Kranz, Alexander
Kornek, Gabriela
Wrba, Fritz
Thurnher, Dietmar
Selzer, Edgar
STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (09) : 832 - 838
[26] Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure
Christiaens, Melissa
Collette, Sandra
Overgaard, Jens
Gregoire, Vincent
Kazmierska, Joanna
Castadot, Pierre
Giralt, Jordi
Grant, Warren
Tomsej, Milan
Bar-Deroma, Raquel
Montii, Angelo F.
Hurkmans, Coen Wilhelm
Weber, Damien Charles
RADIOTHERAPY AND ONCOLOGY, 2017, 123 (03) : 424 - 430
[27] Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximabSignifikanz der p16-Expression bei mit Radiotherapie und Cetuximab behandelten Patienten mit Kopf-Hals-Tumor
Gregor Heiduschka
Anja Grah
Felicitas Oberndorfer
Rudolf Seemann
Alexander Kranz
Gabriela Kornek
Fritz Wrba
Dietmar Thurnher
Edgar Selzer
Strahlentherapie und Onkologie, 2014, 190 (9) : 832 - 838
[28] Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance
Wang, Shu
Zhuang, Xibing
Gao, Caixia
Qiao, Tiankui
ONCOTARGETS AND THERAPY, 2021, 14 : 867 - 877
[29] Lessons Learned from Deescalation Trials in Favorable Risk HPV-Associated Squamous Cell Head and Neck Cancer-A Perspective on Future Trial Designs
Ventz, Steffen
Trippa, Lorenzo
Schoenfeld, Jonathan D.
CLINICAL CANCER RESEARCH, 2019, 25 (24) : 7281 - 7286
[30] The Prevalence of HPV-Associated Head and Neck Cancers and Positive Predictive Value of p16: A Retrospective and Prospective Analysis of 375 Patients
Mubasher, Adnan
Raza, Roshan
Mahabh, Roshan
Van Denakker, Tayler
Quzi, Muhammad
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S18 - S18

← 1 2 3 4 5 →